Bluefin Capital Management’s Eli Lilly LLY Stock Holding History

Bluefin Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-900	Closed	-$329K	–	362
2022 Q4	$329K	Sell	900 -1,100	-55%	-$390K	0.05%	170
2022 Q3	$647K	Buy	+2,000	New	+$634K	0.06%	163
2022 Q1	–	Sell	-3,460	Closed	-$956K	–	834
2021 Q4	$956K	Buy	3,460 +1,440	+71%	+$365K	0.07%	234
2021 Q3	$467K	Buy	+2,020	New	+$499K	0.05%	289
2021 Q1	–	Sell	-1,300	Closed	-$219K	–	883
2020 Q4	$219K	Buy	+1,300	New	+$194K	0.01%	419
2020 Q1	–	Sell	-32,544	Closed	-$4.28M	–	560
2019 Q4	$4.28M	Buy	+32,544	New	+$3.77M	0.28%	92
2019 Q2	–	Sell	-1,770	Closed	-$230K	–	419
2019 Q1	$230K	Buy	+1,770	New	+$215K	0.03%	202
2015 Q1	–	Sell	-5,489	Closed	-$379K	–	546
2014 Q4	$379K	Buy	+5,489	New	+$371K	0.02%	403

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bluefin Capital Management's LLY Position: Q1 2023 in Review

Bluefin Capital Management sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 900 shares — an estimated $329K sold.

Bluefin Capital Management first reported a position in LLY in Q4 2014 and held it in 8 quarters. The position peaked at $4.28M in Q4 2019. 2,614 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

Bluefin Capital Management reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
Bluefin Capital Management sold 900 Eli Lilly shares in Q1 2023, an estimated $329K.
Bluefin Capital Management first reported a position in Eli Lilly in Q4 2014 and held it in 8 quarters.
Bluefin Capital Management's Eli Lilly position peaked at $4.28M in Q4 2019.
2,614 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Bluefin Capital Management's 13F filing for Q1 2023, filed 15 May 2023.